Effector-target cell interactions in engineered immune-therapy against hematologic malignancies

Understanding how clonal hematopoiesis feeds lymphoma

Overcoming the challenge of T-cell lymphoma treatment by safe and efficacious anti-​CD30 radioimmunotherapy with β-​particle and ultra-​short range Auger and conversion electron emitting radionuclides

Harnessing gut microbiome metabolism for personalized treatment of lymphoma and leukemia